A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
A nanoelectronics-blood-based diagnostic biomarker for
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) R. Esfandyarpour, A. Kashi, M. Nemat-Gorgani, J. Wilhelmy, and R. W. Davis https://doi.org/10.1073/pnas.1901274116
Invest in ME Research welcome the publication of this pilot study looking for a way to develop a diagnostic tool
There is a lot more work that needs to be done such as replicating the findings in another ME/CFS patient cohort and testing the method in other illnesses.
The team recognises this and their first aim was to show that ME/CFS patients differ from healthy controls.
This topic was discussed at the Invest in ME Research #IIMEC13 conference in London last year and we are pleased to welcome Professor Ron Davis and many of his colleagues again to this year’s Invest in ME Research conference on 31st May in London.
Promising research such as this is good news and we hope that funding decisions for ME/CFS research
applications reflect the need to support innovative biomedical research into ME/CFS.
Invest in ME Research and its supporters have crowdfunded research to be performed in Norwich Research Park (and elsewhere) to establish a Centre of Excellence for ME.
The charity is delighted that there is an increasing number of biomedical researchers interested in ME/CFS and we are determined to encourage young researchers to enter this exciting field that is waiting for discoveries to be made.